Search research articles
Contact Us
Filters
Showing results (31-40 of 289) with videos related to
Page
of 29
Sort By:
Tumori
|
February 18, 2015
Rationale and protocol of SOAP: a phase II study to evaluate the efficacy of sorafenib as second-line treatment after pazopanib in patients with advanced renal cell carcinoma
Roberto Iacovelli, Elena Verzoni, Paolo Grassi, et al.
Journal of Kidney Cancer and VHL
|
April 17, 2024
Impressive and Prolonged Response with Lenvatinib in a Highly Pretreated Patient with Metastatic Clear Cell Renal Cancer: A Case Report
Sara Demurtas, Mara Frascaroli, Federico Sottotetti, et al.
Journal of Bone Oncology
|
December 22, 2021
Bone metastases from urothelial carcinoma. The dark side of the moon
Marco Stellato, Daniele Santini, Maria Concetta Cursano, et al.
Drug Design, Development and Therapy
|
July 28, 2016
Cabozantinib in the treatment of advanced renal cell carcinoma: design, development, and potential place in the therapy
Paolo Grassi, Elena Verzoni, Raffaele Ratta, et al.
Future Oncology (London, England)
|
October 26, 2013
Patient approach in advanced/metastatic renal cell carcinoma: focus on the elderly population and treatment-related toxicity
Elena Verzoni, Filippo de Braud, Francesca Fabiani, et al.
Therapeutic Advances in Urology
|
April 2, 2015
Sites of disease as predictors of outcome in metastatic renal cell carcinoma patients treated with first-line sunitinib or sorafenib
Paolo Grassi, Elena Verzoni, Luca Porcu, et al.
Critical Reviews in Oncology/Hematology
|
December 21, 2025
A daily clinical practice decision-making overview for the present metastatic renal cell carcinoma (mRCC) management landscape
Sergio Bracarda, Fabio Calabrò, Ugo De Giorgi, et al.
Frontiers in Oncology
|
May 20, 2020
Coronavirus: Older Persons With Cancer in Italy in the COVID-19 Pandemic
Lucia Fratino, Giuseppe Procopio, Massimo Di Maio, et al.
ESMO Open
|
March 25, 2020
Acute kidney injury from contrast-enhanced CT procedures in patients with cancer: white paper to highlight its clinical relevance and discuss applicable preventive strategies
Laura Cosmai, Camillo Porta, Carmelo Privitera, et al.
Critical Reviews in Oncology/Hematology
|
October 24, 2024
Pharmacological treatment landscape of non-metastatic hormone-sensitive prostate cancer: A narrative review on behalf of the meet-URO Group
Emilio Francesco Giunta, Giandomenico Roviello, Vincenza Conteduca, et al.
Page
of 29
Search research articles
Search
Showing results (31-40 of 289) with videos related to
Sort By:
Page
of 29
Tumori
|
February 18, 2015
Rationale and protocol of SOAP: a phase II study to evaluate the efficacy of sorafenib as second-line treatment after pazopanib in patients with advanced renal cell carcinoma
Roberto Iacovelli, Elena Verzoni, Paolo Grassi, et al.
Journal of Kidney Cancer and VHL
|
April 17, 2024
Impressive and Prolonged Response with Lenvatinib in a Highly Pretreated Patient with Metastatic Clear Cell Renal Cancer: A Case Report
Sara Demurtas, Mara Frascaroli, Federico Sottotetti, et al.
Journal of Bone Oncology
|
December 22, 2021
Bone metastases from urothelial carcinoma. The dark side of the moon
Marco Stellato, Daniele Santini, Maria Concetta Cursano, et al.
Drug Design, Development and Therapy
|
July 28, 2016
Cabozantinib in the treatment of advanced renal cell carcinoma: design, development, and potential place in the therapy
Paolo Grassi, Elena Verzoni, Raffaele Ratta, et al.
Future Oncology (London, England)
|
October 26, 2013
Patient approach in advanced/metastatic renal cell carcinoma: focus on the elderly population and treatment-related toxicity
Elena Verzoni, Filippo de Braud, Francesca Fabiani, et al.
Therapeutic Advances in Urology
|
April 2, 2015
Sites of disease as predictors of outcome in metastatic renal cell carcinoma patients treated with first-line sunitinib or sorafenib
Paolo Grassi, Elena Verzoni, Luca Porcu, et al.
Critical Reviews in Oncology/Hematology
|
December 21, 2025
A daily clinical practice decision-making overview for the present metastatic renal cell carcinoma (mRCC) management landscape
Sergio Bracarda, Fabio Calabrò, Ugo De Giorgi, et al.
Frontiers in Oncology
|
May 20, 2020
Coronavirus: Older Persons With Cancer in Italy in the COVID-19 Pandemic
Lucia Fratino, Giuseppe Procopio, Massimo Di Maio, et al.
ESMO Open
|
March 25, 2020
Acute kidney injury from contrast-enhanced CT procedures in patients with cancer: white paper to highlight its clinical relevance and discuss applicable preventive strategies
Laura Cosmai, Camillo Porta, Carmelo Privitera, et al.
Critical Reviews in Oncology/Hematology
|
October 24, 2024
Pharmacological treatment landscape of non-metastatic hormone-sensitive prostate cancer: A narrative review on behalf of the meet-URO Group
Emilio Francesco Giunta, Giandomenico Roviello, Vincenza Conteduca, et al.
Page
of 29